For startups, getting a drug to market is a marathon but founders need to think beyond filing patents to win over investors, ...

Disputed drug forms part of a multi-billion dollar franchise for J&J, ranking among its largest revenue drivers in mental ...

4 February 2025 LSIPR sister title WIPR releases USA Patents Rankings, divided into categories of non-contentious and ...

LSPN panellists from Mathys & Squire discuss recent developments affecting the EPO Boards of Appeal and decisions emerging ...

California medical device company sues rival at the ITC and in Delaware court over “copycat” brain monitoring system launch in May | Ceribell accuses competitor of “a history of willful patent ...

German and Finnish pharma giants sue Indian rival in Delaware court | Dispute centres on generic bid for prostate cancer ...

Office declined application, citing earlier authorisations for inhalers designed for people containing the same ingredient | Boehringer argued that ciclesonide was a ‘new active substance’ not ...

New addition expected to strengthen firm’s foundational ‘IP’ practice. If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, ...

Biocon failed to provide critical information about proposed denosumab product, Amgen claims | Company expects ‘sales erosion ...

Judge says sale of genetic data is ‘scary proposition’ but that blanket ban could result in missed opportunities | Former CEO ...

17 June 2025 Ex-co-head of life sciences at previous firm brings expertise in multi-jurisdictional patent disputes involving ...

8 November 2017 Generic drugs maker Accord Healthcare has lost a battle to have a patent invalidated at the English High ...